Lucius Cabozantinib – Acheter en ligne

EUR 121.33

1,700+ vendus
Prix promo

Pharmacie physique à Hong Kong, authenticité 100% garantie

Points forts

MET AXL VEGFR , 2012 11 29 (FDA) ,

Garanties de service

Expédition transfrontalièrePharmacie agrééeContrôle pharmacienGarantie authenticité

Caractéristiques

Spécification
20mg*90 comprimes
Fabricant
Lucius Pharmaceuticals
Expédition
Hong Kong

10000 en stock

Catégories : , Étiquettes : , , , , Marque :

Informations produit

Nom anglais
Cabozantinib
Nom générique
Cabozantinib

Caractéristiques

Spécification
20mg*90 comprimes
Fabricant
Lucius Pharmaceuticals
Expédition
Hong Kong

Détails complets

Mécanisme d’action

/ , MET VEGFR-1 -2 -3 AXL RET ROS1 TYRO3 MER KIT TRKB FLT-3 TIE-2

Pharmacologie

12.1 Mecanisme d action / , MET VEGFR-1 -2 -3 AXL RET ROS1 TYRO3 MER KIT TRKB FLT-3 TIE-2 12.2 - QTc

Precautions

5.1 CABOMETYX CABOMETYX RCC HCC DTC , CABOMETYX 3 5 5% [ (6.1)] , 3 CABOMETYX 3 4 CABOMETYX [ Posologie (2.3) Precautions (5.11, 5.12)]

Interactions médicamenteuses

7.1 CYP3A4 CYP3A4 , [ (12.3)] CYP3A4 CYP3A4 , [ Posologie(2.4)] ,

Effets indésirables

Details complets [ Precautions (5.1)] [ Precautions (5.2)] [ Precautions (5.3)] [ Precautions (5.4)] [ Precautions (5.5)] [ Precautions (5.6)] [ Precautions (5.7)] [ Precautions (5.8)] [ Precautions (5.9)] [ Precautions (5.10)] [ Precautions (5.11)]Precautions 5.11 ] [se

Package Insert

Effets indésirables

Details complets [ Precautions (5.1)] [ Precautions (5.2)] [ Precautions (5.3)] [ Precautions (5.4)] [ Precautions (5.5)] [ Precautions (5.6)] [ Precautions (5.7)] [ Precautions (5.8)] [ Precautions (5.9)] [ Precautions (5.10)] [ Precautions (5.11)]Precautions 5.11 ] [se

Precautions

5.1 CABOMETYX CABOMETYX RCC HCC DTC , CABOMETYX 3 5 5% [ (6.1)] , 3 CABOMETYX 3 4 CABOMETYX [ Posologie (2.3) Precautions (5.11, 5.12)]

Use in Pregnancy and Lactation

8.1 Mecanisme d action,COMETRIQ [ (12.1)] , , , ,

Interactions médicamenteuses

7.1 CYP3A4 CYP3A4 , [ (12.3)] CYP3A4 CYP3A4 , [ Posologie(2.4)] ,

Clinical Pharmacology

12 12.1 Mecanisme d action / , RET MET VEGFR-1 -2 -3 KIT TRKB FLT-3 AXL ROS1 TYRO3 MER TIE-2 12.2 , COMETRIQ 140 mg MTC QTc COMETRIQ 4 , QTcF 10-15 QTc

Pharmacology and Toxicology

13 13.1 rasH2 Sprague-Dawley 2 , , , 1 mg/kg 140 mg AUC 0.6 , / 26 rasH2 , Ames ,

Clinical Studies

14 1 , 330 (MTC) COMETRIQ 14 , (IRRC) IRRC , 89% , 11% 2:1 , COMETRIQ 140 mg (n = 219) (n = 111) , , , ≤ 65 vs. > 65 (TKI) vs.

Avis produit (11)

Filtre : Tous les avis
4.7★★★★★
11 avis clients9 achats verifies
+o***e· il y a 3 semaines
★★★★
+t***3· il y a 1 mois
Achat verifie
★★★★★

Description

Mécanisme d’action

/ , MET VEGFR-1 -2 -3 AXL RET ROS1 TYRO3 MER KIT TRKB FLT-3 TIE-2

Pharmacologie

12.1 Mecanisme d action / , MET VEGFR-1 -2 -3 AXL RET ROS1 TYRO3 MER KIT TRKB FLT-3 TIE-2 12.2 - QTc

Precautions

5.1 CABOMETYX CABOMETYX RCC HCC DTC , CABOMETYX 3 5 5% [ (6.1)] , 3 CABOMETYX 3 4 CABOMETYX [ Posologie (2.3) Precautions (5.11, 5.12)]

Interactions médicamenteuses

7.1 CYP3A4 CYP3A4 , [ (12.3)] CYP3A4 CYP3A4 , [ Posologie(2.4)] ,

Effets indésirables

Details complets [ Precautions (5.1)] [ Precautions (5.2)] [ Precautions (5.3)] [ Precautions (5.4)] [ Precautions (5.5)] [ Precautions (5.6)] [ Precautions (5.7)] [ Precautions (5.8)] [ Precautions (5.9)] [ Precautions (5.10)] [ Precautions (5.11)]Precautions 5.11 ] [se